As of 2025-07-12, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 14.2x | 13.8x |
| Forward P/E multiples | 23.2x - 30.9x | 27.2x |
| Fair Price | (34.42) - (20.18) | (30.19) |
| Upside | -190.1% - -152.8% | -179.0% |
| Date | EV/EBITDA |